University of California-San Francisco
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hsiao, Edward
ANDECAL, NCT06508021: A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Recruiting
2/3
92
US
Andecaliximab, Placebo
Ashibio Inc
Fibrodysplasia Ossificans Progressiva
02/29
02/29
NCT06724562: This is an Observational Pre-post Study to Observe if the Off Label Use of Anti-IL1 Therapies, Such as Anakinra or Canakinumab, Can Block ACVR1-induced Flare Activity and Heterotopic Ossification in FOP

Not yet recruiting
N/A
11
US
Anti-IL1 Therapy, Canakinumab, Anakinra
University of California, San Francisco, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Fibrodysplasia Ossificans Progressiva (FOP)
01/27
01/27
Lee, Janet
NCT06326710: The 'Outdoor Rehab-Fit' App-based Physical Activity Education Intervention for Frail Older Adults in Hong Kong

Completed
N/A
36
RoW
mHealth, Health Talk
The Hong Kong Polytechnic University
Physical Inactivity, Frailty
10/24
10/24
Miller, Lacey
No trials found

Download Options